Effects of acute-phase COVID-19-related indicators on pulmonary fibrosis and follow-up evaluation.

ABSTRACT:

Background

Post-COVID-19 pulmonary fibrosis is a significant long-term respiratory morbidity affecting patients' respiratory health. This exploratory study aims to investigate the incidence, clinical characteristics, and acute-phase risk factors for pulmonary fibrosis in COVID-19 patients. Additionally, it evaluates pulmonary function and chest CT outcomes to provide clinical evidence for the early identification of high-risk patients and the prevention of post-COVID-19 pulmonary fibrosis.

Methods

We retrospectively analyzed 595 patients hospitalized for COVID-19 from January 2022 to July 2023. Patients were divided into fibrosis and nonfibrosis groups on the basis of imaging changes. Baseline data, including demographics, disease severity, laboratory indicators, and chest i

SUBMITTER: Wang Q 

PROVIDER: S-EPMC11657883 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature